Back to search
Scientific Name: Deucravacitinib
Brand Name: Sotyktu
Company Owner: Not Available
Mechanism Of Action Tyrosine kinase 2 (TYK2) is a member of the Janus kinase (JAK) family of kinases, which are intracellular tyrosine kinases that activate the JAK–signal transducer and activator of the transcription pathway. Unlike other members of the JAK family that promote broader immune and extra-immune pathways, such as lipid metabolism, the TYK2 signalling pathway is responsible for selected immune pathways.
Description of the Drug: Deucravacitinib is a TYK2 inhibitor being investigated as a treatment for psoriasis.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from